We use cookies for a better user experience. Read our Privacy Policy

I Agree

Healthcare Specialty Enzymes Market

Healthcare Specialty Enzymes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020–2030

Healthcare Specialty Enzymes Market: Introduction

Enzymes are complex proteins capable of inducing chemical changes in other substances without being changed themselves. The specificity of enzymes to certain tissues or organs aids in identifying the site of damage, which helps in disease diagnosis. Changing levels of Lactate Dehydrogenase (LDH) in the blood is a preferred approach to detect the onset of cardiovascular diseases; this enzyme is specifically found in the heart and skeletal muscle in two distinguished forms.

 Key Drivers and Restraints of Global Healthcare Specialty Enzymes Market

  • Specialty enzymes are employed in various diagnostic applications such as DNA manipulation and sequencing. Decline in cost of DNA manipulation and sequencing is projected to drive the demand and increase usage of enzymes in research & biotechnology and pharmaceuticals applications. Increase in geriatric population in developed countries is also anticipated to propel the demand for healthcare specialty enzymes. Research & biotechnology application of enzymes is estimated to increase at a rapid pace, as advances in diagnostic tests due to decline in DNA sequencing costs are likely to lead to increase in testing in agricultural, food, and medical applications. Moreover, large pharmaceutical companies continue to boost research & development spending on biologics to expand their new drug pipelines.
  • Investments by various multinational enzyme manufacturers operating in the global healthcare specialty enzymes market, such as Novozymes, Codexis, and Biocatalysts, has been increasing for the last few years. The healthcare specialty enzymes market is driven by continued investment in biotechnology and genetics, as pharmaceutical companies rely on biotechnology to overcome difficulties in introducing successful new small molecule drugs to the market.
  • The enzyme industry is concentrated, with top players dominating the market. This is because enzyme products require specialized knowledge of manufacturing processes such as fermentation. Technical and niche nature of the business, reliance on R&D, and shortage of qualified professionals act as entry barriers for new players in the global specialty enzyme market.

Polymerases & nucleases segment to dominate global healthcare specialty enzymes market

  • Based on type, the global healthcare specialty enzymes market can be divided into carbohydrases, proteases, lipases, polymerases & nucleases and others. The carbohydrases segment can be further sub-segmented into amylases, cellulases, and other.
  • The polymerases & nucleases segment dominated the market, in terms of revenue, in 2019. Rise in usage of polymerase and nuclease enzymes in advanced biotech applications, such as DNA sequencing and DNA amplification, fuels the segment. A shift from immunoassay and biochemistry analysis to molecular diagnostics and adoption of genetic testing for various prenatal diseases and infectious diseases drives the polymerases and nucleases segment. The segment is also projected to expand at a robust growth rate during the forecast period owing to increased focus of manufacturers on the development of polymerases and nucleases.

Pharmaceuticals Witness Highest Growth

  • Based on application, the global healthcare specialty enzymes market can be divided into pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts
  • The pharmaceuticals segment dominated the global market in 2019. It is projected to maintain its position during the forecast period. Pharmaceutical companies such as Sanofi India, Alkem Labs, Emcure Pharma and Torrent Pharma use these healthcare specialty enzymes as active ingredients in their drugs and nutraceuticals for the treatment of various diseases. In nutraceuticals, which are primarily US focused, the company uses these enzymes in dietary supplements, functional foods such as breakfast cereals, sports drinks, etc.
  • The research & biotechnology segment is estimated to expand at a considerable CAGR during the forecast period

Microorganisms segment to dominate global healthcare specialty enzymes

  • Based on source, the global healthcare specialty enzymes market can be segregated into microorganisms, plants, and animals
  • In terms of revenue, the microorganisms segment accounted for a notable share of the market in 2019 owing to the unique characteristics induced in enzymes derived from microbes. Fermented microbial enzyme products offer several advantages including broad ranges of pH, temperatures, and varied specificities regarding the substrate. Key factors that encourage manufacturers to opt for enzymes from microbial sources are their active and stable nature and their capability to degrade a wide range of complex substrates into more useful energy sources.

North America to dominate global healthcare specialty enzymes market

  • In terms of region, the global healthcare specialty enzymes market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • North America accounted for a prominent share of the global healthcare specialty enzymes market in 2019. Introduction of new policies, such as Affordable Care Act, has increased the demand for high-quality healthcare facilities. Demand for preventive healthcare is another factor driving the healthcare specialty enzymes market, which in turn is fueling the healthcare specialty enzymes market in North America.
  • Developing economies in Asia Pacific and Latin America provide significant opportunities in the healthcare specialty enzymes market owing to government initiatives, such as awareness programs and increase in geriatric population that is more prone to metabolic diseases and certain metabolic disorders that would lead to a large potential patient base, is likely to boost the healthcare specialty enzymes market in these regions. For instance, the healthcare expenditure in China is likely to increase from US$ 357 Bn in 2011 to around US$ 1,000 Bn by 2020.

Key Manufacturers Operating in Market

The global healthcare specialty enzymes market was highly fragmented in 2019. Key manufacturers operating in the global market are:

  • BASF
  • Novozymes
  • Roche Holding
  • DuPont
  • Codexis
  • Dyadic International
  • Advanced Enzymes
  • Amano Enzymes
  • Sanofi
  • Biocatalysts
  • Enzyme Supplies
  • BBI Solutions
  • Specialty Enzymes & Probiotics
  • Amicogen
  • Antozyme Biotech
  • Enzyme Development Corporation
  • Nagase & Co. Ltd.
  • Sekisui Diagnostics
  • Merck
  • Biovet

Healthcare Specialty Enzymes Market: Research Scope

Healthcare Specialty Enzymes Market, by Type

  • Carbohydrases
    • Amylases
    • Cellulases
    • Other
  • Proteases
  • Lipases
  • Polymerases & Nucleases
  • Others

Healthcare Specialty Enzymes Market, by Application

  • Pharmaceuticals
  • Research & Biotechnology
  • Diagnostics
  • Biocatalysts

Healthcare Specialty Enzymes Market, by Source

  • Microorganisms
  • Plants
  • Animals

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes


Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.


Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved